Table 5: Anti-rejection treatments and outcomes received by AMR patients.

Therapy after rejection

N (%)          

Hemodialysis despite treatment after 1 month(N-%)

Hemodialysis despite treatment after 3 months(N-%)

Corticosteroids+Plasmapheresis+IVIG

8 (25)

4(30.8)

5(33.3)

Corticosteroids +IVIG+ Rituximab

13 (40.6)

3(23.1)

4(26.7)

Corticosteroids+Plasmapheresis+IVIG+

Rituximab

11 (34.4)

6(46.2)

6(40.0)